Shenzhen Purcotton Technology Co. Ltd announced that it expects to receive CNY 80 million in funding from ShanXi C&Y Pharmaceutical Group Co., LTD.
Shenzhen PurCotton Technology Co., Ltd. announced that it will receive CNY 80,000,000 in equity round of funding from existing investor ShanXi C&Y Pharmaceutical Group Co., Ltd. (SZSE:300254) on November 27, 2020. The investor continues to own 100% stake in the company. The transaction has been approved by the 15th meeting of the 2nd directorate and the 9th meeting of the 2nd supervisory board of the investor and does not need the shareholders’ approval.